# Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments

> **NCT00590694** · PHASE2,PHASE3 · COMPLETED · sponsor: **Pacific Eye Associates** · enrollment: 15 (actual)

## Conditions studied

- Age-related Macular Degeneration
- Pigment Epithelial Detachment
- Neovascular Macular Degeneration
- Wet Macular Degeneration

## Interventions

- **DRUG:** ranibizumab

## Key facts

- **NCT ID:** NCT00590694
- **Lead sponsor:** Pacific Eye Associates
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2012-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00590694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00590694, "Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00590694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*